|1.||Salem, Riad: 19 articles (08/2015 - 02/2005)|
|2.||Lewandowski, Robert J: 11 articles (08/2015 - 08/2005)|
|3.||Gordon, Leo I: 8 articles (09/2007 - 02/2002)|
|4.||Carr, Brian I: 7 articles (08/2012 - 02/2005)|
|5.||Emmanouilides, Christos: 7 articles (09/2007 - 02/2002)|
|6.||Witzig, Thomas E: 6 articles (07/2013 - 02/2002)|
|7.||Schilder, Russell J: 6 articles (09/2007 - 01/2004)|
|8.||Prous, J R: 6 articles (09/2006 - 05/2004)|
|9.||Rabasseda, X: 6 articles (09/2006 - 05/2004)|
|10.||Omary, Reed A: 5 articles (03/2014 - 08/2005)|
01/01/2015 - "The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization."
03/01/2013 - "To propose a new method to estimate lung mean dose (LMD) using technetium-99m labeled macroaggregated albumin ((99m)Tc-MAA) single photon emission CT (SPECT)/CT for (90)Yttrium radioembolization of liver tumors and to compare the LMD estimated using SPECT/CT with clinical estimates of LMD using planar gamma scintigraphy (PS). "
10/21/2011 - "Bioactive glasses as potential radioisotope vectors for in situ cancer therapy: investigating the structural effects of yttrium."
07/01/2011 - "Trans-arterial (90)yttrium radioembolization for patients with unresectable tumors originating from the biliary tree."
06/01/2011 - "Gastric ulceration is a relatively uncommon but well-described complication of yttrium 90 (Y90) radioembolization therapy in the locoregional treatment of hepatic tumors. "
|2.||Non-Hodgkin Lymphoma (Lymphosarcoma)
03/01/2007 - "A 75-year-old man with relapsed follicular non-Hodgkin lymphoma confined to a solitary lung mass was treated with radioimmunotherapy (RIT) using yttrium 90-ibritumomab tiuxetan. "
04/01/2003 - "Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma."
04/01/2006 - "Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma."
10/01/2004 - "Ongoing trials with yttrium 90-labeled ibritumomab tiuxetan in patients with non-Hodgkin's lymphoma."
09/01/2004 - "We report updated time-to-event variables of a phase III randomized study comparing yttrium 90-labeled ibritumomab with rituximab standard therapy in 143 rituximab-naive patients with relapsed or refractory low-grade, follicular, or transformed CD20+ non-Hodgkin's lymphoma (NHL). "
|3.||Neoplasm Metastasis (Metastasis)
01/01/2015 - "Alternative therapeutic methods for isolated liver metastases include radioembolization with yttrium 90 (Y90) and transarterial chemoembolization (TACE). "
01/01/2014 - "The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review."
06/01/2010 - "Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases."
09/10/1982 - "[Yttrium-90-therapy of bone metastases]."
07/01/2011 - "Yttrium microspheres have been used successfully to treat liver metastasis from DSRCT. "
01/01/2014 - "The aim of this study was to investigate the efficacy of the sequential combined 585 nm PDL and the 1064 nm neodymium:yttrium-aluminium-garnet laser (PDL/Nd:YAG) in the treatment of surgical scars and to evaluate the short-term effects by in vivo confocal microscopy (RCM) and the long-term effects by clinical assessment of the scars. "
06/01/2006 - "Anterior stromal puncture with insulin needles or Neodymium : aluminium-yttrium-garnet may enhance the epithelial adhesion to the basement membrane by scar formation and success rates of up to 80% have been reported in the treatment of recalcitrant RCE. "
03/01/2013 - "Our aim was to assess the improvement of facial acne scars with Erbium-doped Yttrium Aluminium Garnet (Er:YAG) 2940 nm fractional laser resurfacing and its adverse effects in 25 patients at a tertiary care teaching hospital. "
03/01/2013 - "Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars."
04/01/2012 - "The aim of this study was to assess the efficacy and safety of ablative fractional yttrium-scandium-gallium-garnet (YSGG) laser in patients with residual haemangiomas or with scarring after their surgery. "
|5.||Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/01/2014 - "(90) Yttrium ((90) Y)-Ibritumomab-Tiuxetan combines the targeting advantage of a monoclonal antibody with the radiosensitivity of Follicular Lymphoma (FL). "
08/01/2014 - "Yttrium 90-ibritumomab tiuxetan (90Y-IT) radioimmunotherapy has proved to be effective in relapsed follicular lymphoma (FL). "
03/01/2014 - "Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. "
01/01/2007 - "Ibritumomab, an (90)Yttrium ((90)Y) labelled radioimmunoconjugate, is registered in Europe to treat follicular lymphomas. "
07/01/2006 - "90Y-ibritumomab tiuxetan is a monoclonal antibody directed against the CD20 antigen to which a radioactive isotope of yttrium is attached, used for treating follicular lymphomas (FL). "
|5.||ibritumomab tiuxetan (Zevalin)
|8.||Sodium Hypochlorite (Clorox)